Author response: Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients
Cécile Alanio(Inserm), Matthew L. Albert(Radiant Genomics (United States)), A. Garbarg‐Chenon(Sorbonne Université), Vincent Mallet(Université Paris Cité), Marit M. van Buuren(The Netherlands Cancer Institute), Kerstin Johnsson(Lund University), Darragh Duffy(Inserm), Emmanuel Clave(Hôpital Saint-Louis), Laurence Bousquet(Délégation Paris 5), Aurélie Schnuriger(Sorbonne Université), Philippe Sultanik(Institut Pasteur), Victor Appay(Inserm), Robert Thimme(University of Freiburg), Brieuc P. Pérot(Institut Pasteur), Francesco Nicoli(University of Ferrara), Elisabetta Bianchi(Institut Pasteur), Stanislas Pol(Université Paris Cité), Estelle Mottez(Institut Pasteur), Farhad Heshmati(Hôpital Cochin), Jérémy Boussier(Hôpital Avicenne), Antoine Toubert(Inserm), Tobias Flecken(University of Freiburg), Ton N. Schumacher(Leiden University Medical Center)
Cited by 2
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Genomic analysis of the host response to hepatitis C virus infection
|Proceedings of the National Academy of Sciences|2002|1.2k